National Research Total Assets Over Time
| NRC Stock | USD 19.48 0.06 0.31% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out National Research Performance and National Research Correlation. National |
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Research. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Research listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.25) | Dividend Share 0.48 | Earnings Share 1.12 | Revenue Per Share 6.013 | Quarterly Revenue Growth (0.06) |
The market value of National Research Corp is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Research's value that differs from its market value or its book value, called intrinsic value, which is National Research's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Research's market value can be influenced by many factors that don't directly affect National Research's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Research's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Research is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Research's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Total Assets Analysis
Compare National Research Corp and related stocks such as Evolent Health, Simulations Plus, and Privia Health Group Total Assets Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EVH | 16.3 M | 16.3 M | 16.3 M | 102 M | 38.3 M | 1 B | 1.2 B | 1.3 B | 1.7 B | 1.5 B | 1.4 B | 1.4 B | 1.8 B | 2.7 B | 2.8 B |
| SLP | 1000 K | 17.3 M | 16.1 M | 21 M | 27.3 M | 28 M | 38.5 M | 43.3 M | 45.2 M | 168.4 M | 180 M | 188.4 M | 186.1 M | 196.6 M | 206.5 M |
| PRVA | 270.2 M | 270.2 M | 270.2 M | 270.2 M | 270.2 M | 270.2 M | 270.2 M | 270.2 M | 270.2 M | 270.2 M | 329 M | 686.4 M | 792.8 M | 999.9 M | 677.2 M |
| HSTM | 17.5 M | 154.2 M | 174.5 M | 212.6 M | 257.3 M | 379.6 M | 396 M | 411.1 M | 440.2 M | 489.5 M | 500.3 M | 486.8 M | 497.7 M | 499.9 M | 524.9 M |
| CERT | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1 B | 1.3 B | 1.5 B | 1.6 B | 1.6 B | 1.5 B |
| PHR | 57.1 M | 57.1 M | 57.1 M | 57.1 M | 57.1 M | 57.1 M | 57.1 M | 57.1 M | 59.3 M | 158.8 M | 326.7 M | 494.5 M | 370.1 M | 370.3 M | 288.6 M |
| FORA | 179 K | 179 K | 179 K | 179 K | 179 K | 179 K | 179 K | 179 K | 179 K | 179 K | 12.6 M | 56.8 M | 46.3 M | 58.9 M | 38.4 M |
| HQY | 46.3 M | 46.3 M | 46.3 M | 55.1 M | 158.8 M | 219.8 M | 279.1 M | 369.2 M | 510 M | 2.6 B | 2.7 B | 3.1 B | 3.1 B | 3.2 B | 3.3 B |
| HCAT | 110.3 M | 110.3 M | 110.3 M | 110.3 M | 110.3 M | 110.3 M | 110.3 M | 110.3 M | 111 M | 302.4 M | 577.7 M | 832.1 M | 752.3 M | 701.8 M | 532.3 M |
National Research Corp and related stocks such as Evolent Health, Simulations Plus, and Privia Health Group Total Assets description
Total assets refers to the total amount of National Research assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in National Research Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.My Equities
My Current Equities and Potential Positions
| National Research Corp | NRC |
Specialization | Health Care, Health Care Equipment & Services |
| Location | Nebraska; U.S.A |
| Exchange | NASDAQ Exchange |
USD 19.48
Check out National Research Performance and National Research Correlation. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
National Research technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.